MedTrace Logo

Nicergoline Use in Dysphagia Patients

NCT05551182 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2026-03-04

No results posted yet for this study

Summary

Dysphagia is a complication in patient with stroke, Parkinson's disease or dementia that can lead to aspiration pneumonia. This study aimed to investigate dysphagia improvement after treatment with nicergoline low dose and high dose, the relationship between nicergoline dose and clinical improvements, side effect of nicergoline and simulation optimal nicergoline dose in dysphagia improvement.

Conditions

Interventions

DRUG

Nicergoline

The participants in both arms will receive nicergoline for treatment dysphagia 12 weeks.

Sponsors & Collaborators

  • Silpakorn University

    collaborator OTHER

  • Phramongkutklao College of Medicine and Hospital

    lead OTHER

Principal Investigators

  • Jutikan Imsub, PharmD · College of Pharmacy, Burapha university

  • Sittichoke Sirimontakan, MD · Phramongkutklao hospital and College of Medicine

  • Juthathip Suphanklang, BCP · Phramongkutklao hospital and College of Medicine

  • Pasiri Sithinamsuwan, MD · Phramongkutklao hospital and College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-07-31
Completion
2025-08-20

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05551182 on ClinicalTrials.gov